Mycapssa Capsule, Delayed Release
Product Images NDC 69880-120

5 FDA label images from Amryt Pharmaceuticals Designated Activity Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycapssa (NDC 69880-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amryt Pharmaceuticals Designated Activity Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycapssa 1

Mycapssa 1
Chemical structure of Octreotide showing its peptide chain composition with specific amino acids and a variable methyl group (x) ranging from 1.4 to 2.5. The diagram highlights the molecular arrangement relevant to the active ingredient in Mycapssa capsules.*
FDA Label Image

Mycapssa 2

Mycapssa 2
Illustration showing a three-step procedure to open a blister pack. Step 1: Push on one side of the pack. Step 2: Pull the pack open. Step 3: Unfold the blister pack to access the capsules inside.*
FDA Label Image

Mycapssa 3

Mycapssa 3
An instructional diagram showing how to properly push out a delayed-release capsule from a blister pack by gently pressing with the tip of the thumb. It also includes cautions against using two thumbs or pressing the middle of a capsule to avoid damage.*
FDA Label Image

Mycapssa 4

Mycapssa 4
Packaging label for Mycapssa 20 mg delayed-release oral capsules by Amryt Pharmaceuticals Designated Activity Company. The blue and orange label includes directions to take with water on an empty stomach and indicates a pack size of 28 capsules. The label also shows two blister card outlines for capsules with storage temperature instructions and the product NDC 69880-120-28.*
FDA Label Image

Mycapssa 5

Mycapssa 5
Mycapssa 20 mg delayed-release capsules packaging label showing instructions for use, with 28 capsules per container. The label includes the brand and generic name (octreotide), dosage form (capsule, delayed release), and manufacturer Amryt Pharmaceuticals. The design features blue and orange colors, a barcode, and storage instructions. The label also highlights to keep out of reach of children and includes a push and pull mechanism for opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.